Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2003 Jul;62(7):655–658. doi: 10.1136/ard.62.7.655

Antibiotic treatment and long term prognosis of reactive arthritis

K Laasila 1, L Laasonen 1, M Leirisalo-Repo 1
PMCID: PMC1754599  PMID: 12810429

Abstract

Objective: To evaluate whether a three month course of lymecycline has an effect on the long term prognosis of reactive arthritis (ReA).

Methods: In 1987–88 a double-blind controlled study with three month course of lymecycline/placebo was conducted. 17 of 23 patients treated at the outpatient department of Helsinki University Central Hospital volunteered to take part in a follow up study, where a physical examination were performed, and erythrocyte sedimentation rate, C reactive protein, rheumatoid factor, and radiographs of the lumbosacral spine and sacroiliac joints and of symptomatic peripheral joints were examined.

Results: 16/17 (94%) patients reported some kind of back pain and 10/17 (59%) peripheral joint symptoms during the follow up. Two patients had unilateral grade 1 sacroiliitis, one patient grade 4 sacroiliitis, and one patient bilateral grade 2 sacroiliitis. In one patient the disease had progressed to ankylosing spondylitis (AS), and in another to chronic spondyloarthropathy. In addition, two patients had small erosions in radiocarpal joints. No statistically significant differences were found between placebo and lymecycline groups in the development of chronic arthritis, sacroiliitis, or AS.

Conclusion: The results of the initial study showed that long term treatment with lymecycline in patients with acute ReA decreased the duration of arthritis in those with Chlamydia trachomatis triggered ReA, but not in other patients with ReA. Ten years after the acute arthritis one patient had developed AS, and three had radiological sacroiliitis, three patients had radiological changes at peripheral joints. Long term lymecycline treatment did not change the natural history of the disease.

Full Text

The Full Text of this article is available as a PDF (131.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardin T., Enel C., Cornelis F., Salski C., Jorgensen C., Ward R., Lathrop G. M. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum. 1992 Feb;35(2):190–194. doi: 10.1002/art.1780350210. [DOI] [PubMed] [Google Scholar]
  2. Bardin T., Lathrop G. M. Postvenereal Reiter's syndrome in Greenland. Rheum Dis Clin North Am. 1992 Feb;18(1):81–93. [PubMed] [Google Scholar]
  3. Beutler A. M., Whittum-Hudson J. A., Nanagara R., Schumacher H. R., Hudson A. P. Intracellular location of inapparently infecting Chlamydia in synovial tissue from patients with Reiter's syndrome. Immunol Res. 1994;13(2-3):163–171. doi: 10.1007/BF02918277. [DOI] [PubMed] [Google Scholar]
  4. Braun J., Kingsley G., van der Heijde D., Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000 Sep;27(9):2185–2192. [PubMed] [Google Scholar]
  5. Hannu T., Mattila L., Siitonen A., Leirisalo-Repo M. Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis. 2002 Mar;61(3):264–266. doi: 10.1136/ard.61.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lauhio A., Leirisalo-Repo M., Lähdevirta J., Saikku P., Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991 Jan;34(1):6–14. doi: 10.1002/art.1780340103. [DOI] [PubMed] [Google Scholar]
  7. Leirisalo-Repo M., Suoranta H. Ten-year follow-up study of patients with Yersinia arthritis. Arthritis Rheum. 1988 Apr;31(4):533–537. doi: 10.1002/art.1780310410. [DOI] [PubMed] [Google Scholar]
  8. Leirisalo M., Skylv G., Kousa M., Voipio-Pulkki L. M., Suoranta H., Nissilä M., Hvidman L., Nielsen E. D., Svejgaard A., Tilikainen A. Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum. 1982 Mar;25(3):249–259. doi: 10.1002/art.1780250302. [DOI] [PubMed] [Google Scholar]
  9. Pacheco-Tena C., Burgos-Vargas R., Vázquez-Mellado J., Cazarín J., Pérez-Díaz J. A. A proposal for the classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol. 1999 Jun;26(6):1338–1346. [PubMed] [Google Scholar]
  10. Schumacher H. R., Jr Reactive arthritis. Rheum Dis Clin North Am. 1998 May;24(2):261–273. doi: 10.1016/s0889-857x(05)70008-9. [DOI] [PubMed] [Google Scholar]
  11. Sieper J., Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum. 1995 Nov;38(11):1547–1554. doi: 10.1002/art.1780381105. [DOI] [PubMed] [Google Scholar]
  12. Sieper J., Fendler C., Laitko S., Sörensen H., Gripenberg-Lerche C., Hiepe F., Alten R., Keitel W., Groh A., Uksila J. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum. 1999 Jul;42(7):1386–1396. doi: 10.1002/1529-0131(199907)42:7<1386::AID-ANR12>3.0.CO;2-E. [DOI] [PubMed] [Google Scholar]
  13. Wakefield D., McCluskey P., Verma M., Aziz K., Gatus B., Carr G. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum. 1999 Sep;42(9):1894–1897. doi: 10.1002/1529-0131(199909)42:9<1894::AID-ANR14>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  14. Yli-Kerttula T., Luukkainen R., Yli-Kerttula U., Möttönen T., Hakola M., Korpela M., Sanila M., Parviainen J., Uksila J., Vainionpä R. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis. 2000 Jul;59(7):565–570. doi: 10.1136/ard.59.7.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zhang Y., Toivanen A., Toivanen P. Experimental Yersinia-triggered reactive arthritis: effect of a 3-week course of ciprofloxacin. Br J Rheumatol. 1997 May;36(5):541–546. doi: 10.1093/rheumatology/36.5.541. [DOI] [PubMed] [Google Scholar]
  16. van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361–368. doi: 10.1002/art.1780270401. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES